Tablet
Latest Warner-Lambert Company Patents:
- Methods of treating neurofibromatosis type 1 with N-((R))-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
- COMPOSITIONS OF ESSENTIALLY PURE FORM IV OF N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODO-PHENYLAMINO)-BENZAMIDE AND USES THEREOF
- Methods of treating neurofibromatosis with N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
- METHODS OF TREATING NEUROFIBROMATOSIS WITH N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODOPHENYLAMINO)-BENZAMIDE
- Compositions of essentially pure form IV of N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof
Description
FIG. 1 is an enlarged top perspective view of a tablet showing our new design;
FIG. 2 is a right side elevational view, left side being identical thereto;
FIG. 3 is a top plan view, the bottom plan view being identical therewith;
FIG. 4 is a front elevational view, the rear elevation being identical thereto;
Referenced Cited
Patent History
Patent number: D302481
Type: Grant
Filed: Oct 21, 1987
Date of Patent: Jul 25, 1989
Assignee: Warner-Lambert Company (Morris Plains, NJ)
Inventors: Henry A. Miller (Lake Hopatcong, NJ), Michael R. Harris (Hackettstown, NJ), Frank Goodhart (Mendham, NJ), Mahdi B. Fawzi (Flanders, NJ)
Primary Examiner: Wallace R. Burke
Assistant Examiner: Kay H. Chin
Attorney: Ronald A. Daignault
Application Number: 7/111,525
Type: Grant
Filed: Oct 21, 1987
Date of Patent: Jul 25, 1989
Assignee: Warner-Lambert Company (Morris Plains, NJ)
Inventors: Henry A. Miller (Lake Hopatcong, NJ), Michael R. Harris (Hackettstown, NJ), Frank Goodhart (Mendham, NJ), Mahdi B. Fawzi (Flanders, NJ)
Primary Examiner: Wallace R. Burke
Assistant Examiner: Kay H. Chin
Attorney: Ronald A. Daignault
Application Number: 7/111,525
Classifications
Current U.S. Class:
D28/2;
Jeweled (D28/81)
